Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Search Seller Projects – , Healthcare

Page of 5
Europe: Finland

Finish medical R&D company seeks domestic investment or acquisition.

A private company, which is headquartered in Turku, Finland, dedicated to providing innovative diagnostic tools for routine clinical diagnosis and research. Based on its proprietary technology, the company has developed and commercialized the next generation of multifunctional micro detection tools. The advantages of this technology enable it to overcome the performance limitations of the previous generation test in terms of sensitivity, accuracy, ease of use and cost efficiency.
The testing equipment developed by the company has passed ISO 13485:2016 and ISO 9001:2015. This equipment is a cathode electrochemiluminescence instrument that can be used to measure the concentration of components in blood. The technology can be used for animal epidemic prevention. It is convenient and fast to use. The results can be obtained in 5-10 minutes with reliable accuracy. It can be viewed at any time on the independent display screen or mobile phone application on the equipment.
If the matching detection box is used together (the antibody has been wrapped on the chip without calibration), the analyzer can also be used to detect human C-reactive protein (CRP). Results can be displayed in 6-12 minutes from a full blood sample. It can be used to triage patients to reduce uncertainty and avoid unnecessary antibiotic use.
Europe: Britain

British biomedicine company seeks Chinese Partner.

The firm is a Contract Manufacture Organization (CMO) headquartered in the UK, manufacturing and sterile filling bottles for clinical trials and small volume commercial supply. The company was founded in 2011, has sales offices in Boston, the United States. The turnover in 2019 exceeded USD 10 million, and the EBITDA in 2019 exceeded about USD 1.4 million. Core business: sterile production, analysis and microbiological testing, clinical trial services, (CTS): labeling and packaging, release of qualified personnel (QP). The company specializes in production of liquid, lyophilized powder, cytotoxicity, chemical and biopharmaceutical products, including lyophilized powder or liquid, biological agents (peptides, proteins, antibodies, nucleic acids), small molecules and efficient cytotoxins. It has professional facilities: two dust-free rooms with freeze dryer and special cytotoxic and non cytotoxic clean rooms. Test capability: release test, including HPLC, SDS PAGE, ELISA, microbial detection - sterility and endotoxin, etc.
Europe: Britain

British medical equipment company with production in Shenzhen looking for investors to grow their buisiness in China

The company has developed a portfolio of wearable light sources for medical and consumer health applications. There are two distinct product lines. Two products are clinically proven and easy to use for the treatment of specific skin diseases such as non-melanoma skin cancer and acne. The product is manufactured in Shenzhen, and the distribution partner has been appointed in China. It is expected to be provided online in China through T-Mall soon.
Europe: Britain

UK medical equipment manufacturer with clinically proven blood circulation stimulation device seeking investors for expansion to the United States

The company has developed patented neuromuscular electrical stimulation technology and a product that has been clinically proven to increase blood circulation. The product is the size of a watch and is worn behind the knee. It will send a small electric pulse to gently stimulate the common peroneal nerve behind the knee, and then activate the calf and foot muscle pump of the calf to return the blood to the heart. The technique has been developed for the treatment of deep venous thrombosis, advanced wound care, preoperative and postoperative edema reduction, incontinence and athlete rehabilitation. In each clinical field, it improves the prognosis of patients and saves sanitation system resources. The company is raising £ 30-35 million to continue clinical development, product development and marketing in the United States, valued at £ 114 million.
Europe: Britain

Cambridge based biotech R&D firm with unparalleled track record looking for investors

The company is a Cambridge based biotechnology contract research and drug development company, which operates a mixed business model. The revenue is generated through its service business and the development of drug products. The company has an excellent track record in candidate drug delivery. It has a world-class discovery team, and its unparalleled track record shows that it has delivered one candidate drug on behalf of its customers every year in the past six years. Revenue in 2019 was approximately £ 6 million, of which 83% of sales came from a strong growing industrial customer base, which has now become the core of the business.
Europe: France

French medical device company seeking Chinese partners for market development

The company is a French medical device company, and its main business is research, development, production and sales of cervical cancer detection equipment, generating annual sales of over EUR 20 million with an EBITDA of 2 million euros.
Recently, the company is also actively studying covid testing equipment, and the test package developed by its wholly-owned subsidiary has been approved by the FDA, and has been included in the list of WHO licensed emergency use, and the test can be purchased worldwide within one year.
The company's cervical cancer detection equipment has been initially sold in China, where it hopes to find new partners, especially those with good resources in hospitals/laboratories/obstetricians and gynecologists.
Europe: Croatia

Croatian medical device manufacturer seeking investment

The company has developed, manufactured and sold medical devices for orthopedics and traumatology for more than 100 years.
Europe: Britain, United Kingdom

UK medtech SaaS firm with collaboration tool in medical imaging seeking investors

The company has developed a pioneering collaboration platform based on a medical imaging cloud for hospitals, clinics and imaging centers. It provides SaaS solutions for medical imaging management, archiving, viewing, and analysis. Most importantly, it enables medical imaging driven social and professional collaboration among users. In addition to its cloud platform, the company also provides many clinical "applications", such as virtual colonoscopy and vascular analysis.
Europe: Britain, United Kingdom

Britisch medical equipment manufacturer with hair removal and skin rejuvenation technology looking for investors.

The company designs and manufactures IPL (intense pulsed light) hair removal products for consumers. The company is unique in combining technological innovation with clinical understanding of skin-light interaction. The potential of the household devices is very promising. In addition to hair removal, there are opportunities to expand the application of the technology to skin rejuvenation, acne treatment and other beauty applications. In 2019, the turnover exceeded £ 40 million with an EBITDA above £ 7 million.
Europe: Britain, United Kingdom

British Biomedicine R&D firm with new drug against MRSA looking for investors

The company has developed a new anti-infection drug with outstanding and rapid bacterial activity against Staphylococcus aureus (SA), which is the biggest cause of nosocomial bacterial infection in the world. The leading drug has completed clinical trials funded by the US government. Different from traditional antibiotics, this drug shows excellent resistance to SA bacteria in the laboratory where it has produced a series of low bacterial resistance potentials, and can be used to prevent and treat MRSA infection. The company has been listed on the Alternative Investment Market (AIM), a sub-market of London Stock Exchange (LSE), with a market value of 19 million pounds.
North America: United States

Project Loche - Innovative FDA cleared, IP protected wrist wearable solution for continuous remote patient monitoring - Seeking Investment by United States firm

Project Loche (the ‘Company’) is a MedTech and digital health company that has pioneered the full-suite medical continuous care solution. The Company has developed an innovative AI-powered remote patient monitoring solution that includes three patented innovations
Australia: Australia

Healthcare, Innovative aid for tube feeding in people - Australia firm Seeking Investment

Family owned business for sale that has a simple and practical adhesive patented product, like a band aid, that alleviates the need for adhesive tape to apply a feeding tube to a body part, mainly a nasal gastric feeding tube.


Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive